Inhaled corticosteroid dose escalation vs triple therapy in patients with T2-high asthma not controlled by medium doses of inhaled corticosteroid/long-acting beta-agonist combination: a real-life study. TRICORDA (Triple vs.
CLINICAL TRIAL WITH MEDICINES
Clinical trial information
- Promoter: LUIS PEREZ DE LLANO
- Phase: IV
- Execution start: 27/03/2023
- End of execution: 30/09/2024
- IP: CONCEPTION MORALES GARCIA
